Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0001193125-26-134631

Options or other derivatives

  • President and CEO acquired 2,512,828 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Brady Todd C President and CEO 2026-03-27 Grant or award · Stock Option (right to buy) +1,880,510 1,880,510 D: show line 1 in the form
Brady Todd C President and CEO 2026-03-27 Grant or award · Bonus Units +632,318 632,318 D: show line 2 in the form
Loading xslF345X06/ownership.xml…